Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer
Benefits of bisphosphonate clodronate for breast cancer presented at symposium
January 13th, 2005
A new analysis of data from a large-scale study presented at the 27th Annual Charles A. Coltman, Jr. San Antonio Breast Cancer Symposium demonstrated significant additional benefits with the use of the bisphosphonate clodronate, for patients with primary breast cancer, when used in conjunction with standard adjuvant chemotherapy and endocrine therapy. While a previous analysis of the study data showed that adjuvant treatment with clodronate reduced the occurrence of bone metastases and increased survival in this patient group, this new retrospective analysis showed that clodronate treatment also reduced the incidence of skeletal related events (SREs), morbidity, and...
Source: Women's Health Weekly (2005-01-13)
|
